Federica Gnudi

Dr. Federica Gnudi

Istituto Ramazzini, Bologna, Emilia-Romagna, Italy
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Environmental Research
Verified
Journal Article
Closed access
LFL. Falcioni
L. Falcioni
LBL. Bua
L. Bua
ETE. Tibaldi
E. Tibaldi
MLM. Lauriola
M. Lauriola
LAL. De Angelis
L. De Angelis
FBF. Belpoggi
F. Belpoggi

2 June 2016 in Scientific Reports
Verified
Journal Article
Open access
Daria Lucia TrabattoniDaria Lucia Trabattoni
Daria Lucia Trabattoni
FGFederica Gnudi
Federica Gnudi
SISalomè V. Ibba
Salomè V. Ibba
ISIrma Saulle
Irma Saulle
SASimone Agostini
Simone Agostini
mario clericimario clerici
mario clerici
Nitazoxanide (Alinia®, NTZ) and tizoxanide (TIZ), its active circulating metabolite, belong to a class of agents known as thiazolides (TZD) endowed with broad anti-infective activities. TIZ and RM-4848, the active metabolite of RM-5038, were shown to stimulate innate immunity in vitro. Because natural resistance to HIV-1 infection in HIV-exposed seronegative (HESN) individuals is suggested to be associated with strong innate immune responses, we verified whether TIZ and RM-4848 could reduce the in vitro infectiousness of HIV-1. Peripheral blood mononuclear cells (PBMCs) from 20 healthy donors were infected in vitro with HIV-1BaL in the presence/absence of TIZ or RM4848. HIV-1 p24 were measured at different timepoints. The immunomodulatory abilities of TZD were evaluated by the expression of type I IFN pathway genes and the production of cytokines and chemokines. TZD drastically inhibited in vitro HIV-1 replication (>87%). This was associated with the activation of innate immune responses and with the up-regulation of several interferon-stimulated genes (ISGs), including those involved in cholesterol pathway, particularly the cholesterol-25 hydroxylase (CH25H). TZD inhibition of HIV-1 replication in vitro could be due to their ability to stimulate potent and multifaceted antiviral immune responses. These data warrant the exploration of TZD as preventive/therapeutic agent in HIV infection.

15 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
LGLaura Gramantieri
Laura Gramantieri
FGFederica Gnudi
Federica Gnudi
FVFrancesco Vasuri
Francesco Vasuri
DMDaniele Mandrioli
Daniele Mandrioli
FFFrancesca Fornari
Francesca Fornari
CGCatia Giovannini
Catia Giovannini
Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas.

14 June 2014 in Molecular Biology and Evolution
Verified
Journal Article
Closed access
PDF file
Manuela SironiManuela Sironi
Manuela Sironi
Mara BiasinMara Biasin
Mara Biasin
RCRachele Cagliani
Rachele Cagliani
FGFederica Gnudi
Federica Gnudi
ISIrma Saulle
Irma Saulle
mario clericimario clerici
mario clerici
The protein product of the myxovirus resistance 2 (MX2) gene restricts HIV-1 and simian retroviruses. We demonstrate that MX2 evolved adaptively in mammals with distinct sites representing selection targets in distinct branches; selection mainly involved residues in loop 4, previously shown to carry antiviral determinants. Modeling data indicated that positively selected sites form a continuous surface on loop 4, which folds into two antiparallel α-helices protruding from the stalk domain. A population genetics–phylogenetics approach indicated that the coding region of MX2 mainly evolved under negative selection in the human lineage. Nonetheless, population genetic analyses demonstrated that natural selection operated on MX2 during the recent history of human populations: distinct selective events drove the frequency increase of two haplotypes in the populations of Asian and European ancestry. The Asian haplotype carries a susceptibility allele for melanoma; the European haplotype is tagged by rs2074560, an intronic variant. Analyses performed on three independent European cohorts of HIV-1-exposed seronegative individuals with different geographic origin and distinct exposure route showed that the ancestral (G) allele of rs2074560 protects from HIV-1 infection with a recessive effect (combined P = 1.55 × 10−4). The same allele is associated with lower in vitro HIV-1 replication and increases MX2 expression levels in response to IFN-α. Data herein exploit evolutionary information to identify a novel host determinant of HIV-1 infection susceptibility.

1 June 2013 in Immunity
Verified
Journal Article
Closed access
Diego ForniDiego Forni
Diego Forni
RCRachele Cagliani
Rachele Cagliani
UPUberto Pozzoli
Uberto Pozzoli
MCMarta Colleoni
Marta Colleoni
SRStefania Riva
Stefania Riva
Manuela SironiManuela Sironi
Manuela Sironi

1 August 2019 in Acta Histochemica
Verified
Journal Article
Closed access
SPSimona Panzacchi
Simona Panzacchi
FGFederica Gnudi
Federica Gnudi
DMDaniele Mandrioli
Daniele Mandrioli
RMRita Montella
Rita Montella
VSValentina Strollo
Valentina Strollo
ETEva Tibaldi
Eva Tibaldi